Quick Answer
GYRE THERAPEUTICS, INC. reported Total Assets of $166.13 million for fiscal year 2025.
GYRE THERAPEUTICS, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $166.13M | +32.5% |
| 2024 | $125.41M | +7.6% |
| 2023 | $116.54M | +37.5% |
| 2022 | $84.75M | +52.3% |
| 2021 | $55.66M | -41.3% |
| 2020 | $94.85M | -3.8% |
| 2019 | $98.55M | -21.1% |
| 2018 | $124.92M | +216.1% |
| 2017 | $39.51M | +3.7% |
| 2016 | $38.09M | -45.2% |
| 2015 | $69.52M | +2232.1% |
| 2014 | $2.98M | -98.0% |
| 2013 | $145.87M | -23.1% |
| 2012 | $189.58M | -26.6% |
| 2011 | $258.13M | -1.8% |
| 2010 | $262.79M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $159.38M | +27.3% | +4.4% |
| June 30, 2025 | $152.65M | +26.2% | +17.6% |
| March 31, 2025 | $129.79M | +6.4% | +3.5% |
| December 31, 2024 | $125.41M | +7.6% | +0.1% |
| September 30, 2024 | $125.24M | +1156.9% | +3.6% |
| June 30, 2024 | $120.93M | +875.7% | -0.9% |
| March 31, 2024 | $122.01M | +550.7% | +4.7% |
| December 31, 2023 | $116.54M | +309.7% | +1069.6% |
- GYRE THERAPEUTICS, INC. showed an increase of +32.5% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, GYRE THERAPEUTICS, INC.’s total assets has declined by 36.8% (from $262.79 million to $166.13 million).
- The most recent figure is from GYRE THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: